• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

New research teams funded in pancreatic cancer, glioblastoma

New research teams funded in pancreatic cancer, glioblastoma

Dana-Farber/Harvard Cancer Center and the David H. Koch Institute for Integrative Cancer Research at MIT announced this week that they have funded four research teams in a joint collaboration aimed at solving the most intractable challenges in cancer.

The Koch Institute-Dana-Farber/Harvard Cancer Center Bridge Project is designed to help bring the expertise of these two Centers to bear on complex translational problems in cancer research. A particular emphasis is placed on fostering joint approaches by engineers and cancer scientists, both basic and clinical/translational. This application round called for collaborative research projects that focus on critical problems in glioblastoma and pancreatic cancer.

Awards are for $325,000 (total costs) per team project per year for up to two years. Congratulations to the following teams who will receive funding in this first round:

Single-cell functional, genomic, and transcriptomic analysis in Glioblastoma
PIs: Keith Ligon (DFCI), J. Christopher Love (Koch), Matthew Meyerson (DFCI/Broad)

Nano-ARBs: A novel approach to improve drug delivery in PDACs
PIs: Rakesh Jain (MGH), Robert Langer (Koch)

Development of a Pancreatobiliary Chemotherapy Eluting Stent for Pancreatic Ductal Adenocarcinoma
PIs: Jeffrey Clark (MGH), Robert Langer (Koch), Elazer Edelman (Harvard:MIT HST Program)

A Coordinated Effort for Advancing Immunotherapies Against Pancreatic Cancer
PIs: Hidde Ploegh (Whitehead/Koch), Kai W. Wucherpfennig (DFCI), J. Christopher Love (Koch)

Read the full press release.